Related Experiment Video
Updated: Apr 4, 2026

Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice
Published on: August 25, 2023
Coronary microvascular obstruction in acute myocardial infarction
Giampaolo Niccoli1, Giancarla Scalone2, Amir Lerman3
1Institute of Cardiology, Catholic University of the Sacred Heart, Largo F. Vito 1, 00168 Rome, Italy gniccoli73@hotmail.it.
Abstract:
The success of a primary percutaneous intervention (PCI) in the setting of ST elevation myocardial infarction depends on the functional and structural integrity of coronary microcirculation. Coronary microvascular dysfunction and obstruction (CMVO) occurs in up to half of patients submitted to apparently successful primary PCI and is associated to a much worse outcome. The current review summarizes the complex mechanisms responsible for CMVO, including pre-existing coronary microvascular dysfunction, and highlights the current limitations in the assessment of microvascular function. More importantly, at the light of the substantial failure of trials hitherto published on the treatment of CMVO, this review proposes a novel integrated therapeutic approach, which should overcome the limitations of previous studies.
Insights
Coronary microvascular dysfunction and obstruction (CMVO) impacts outcomes after primary percutaneous intervention (PCI) for myocardial infarction. This review explores CMVO mechanisms and proposes a new integrated treatment approach.
Area of Science:
- Cardiology
- Vascular Biology
- Interventional Cardiology
Background:
- Primary percutaneous intervention (PCI) success for ST-elevation myocardial infarction relies on coronary microcirculation.
- Coronary microvascular dysfunction and obstruction (CMVO) affects up to 50% of patients post-PCI, worsening prognosis.
- Existing treatments for CMVO have shown limited success.
Purpose of the Study:
- To review the mechanisms underlying CMVO.
- To discuss current limitations in assessing microvascular function.
- To propose a novel, integrated therapeutic strategy for CMVO.
Main Methods:
- Literature review of mechanisms of CMVO.
- Analysis of current diagnostic limitations.
- Synthesis of evidence to propose a new therapeutic paradigm.
Main Results:
- CMVO involves complex mechanisms, including pre-existing microvascular dysfunction.
- Current methods for assessing microvascular function are limited.
- Previous therapeutic trials for CMVO have largely failed.
Conclusions:
- CMVO is a significant complication of primary PCI with poor outcomes.
- A comprehensive understanding of CMVO mechanisms is crucial.
- An integrated therapeutic approach is needed to effectively manage CMVO.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Myocarditis I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease II: Pathophysiology

